The main component of adipoiol is recombinant human interleukin, which is a polypeptide immune enhancer.It can induce the secretion of interferon and various cytokines.Clinically, it is used for adjuvant therapy of tumor and treatment of cancerous thorax and ascites.

The global Human Interleukin-2 (IL-2) market was valued at US$ million in 2020 and is expected to reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.
This report focuses on Human Interleukin-2 (IL-2) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Human Interleukin-2 (IL-2) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Human Interleukin-2 (IL-2) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
50000 U
100000 U
200000 U
500000 U
1 Million U
2 Million U

Segment by Application
Recombinant Interferon
Recombinant Interleukin
Natural Biological Products
Poison Immune
Gene Therapy
Monoclonal Antibody

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Roche
BMS
Schering-Plough
AbbVie Inc
Alkermes Plc
APT Therapeutics
Mabtech Limited
Philogen
Sinopharm
Jiangsu Jinsili Pharmaceutical
Shenyang Sansheng Pharmaceutical
Beijing Shuanglu Pharmaceutical
Shandong Quangang Pharmaceutical
Shanghai Huaxin Biological high-tech
Beijing Yuance Pharmaceutical
Beijing Sihuan Biological Pharmaceutical
Beijing Sanyuan Gene Pharmaceutical
Shenzhen Kexing Biological Engineering
Shanghai Sanwei Biotechnology
Xiamen Tebao Biological Engineering
Chengdu huashen Biotechnology
Shanghai Pharma Group
Guangdong Xinghao Pharmaceutical